Bariatric surgery procedures have fallen 46.4% since 2022 as prescriptions for semaglutide and tirzepatide rose to 24.17% of eligible adults by Q3 2025, though 75.8% of eligible patients still receive no treatment.
Clinical studies demonstrate GLP-1 receptor agonists like semaglutide and tirzepatide produce substantial weight loss when combined with lifestyle changes, with patients achieving mean reductions of 14.9% body weight over 68 weeks.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07765420 |
A Clinical Trial to Evaluate the Effects of an Electrolyte Supplement on Women's Wellness |
COMPLETED | NA |
| NCT07765407 |
A Clinical Trial to Evaluate the Effects of a Supplement on Supporting Signs of a Healthy Metabolism |
COMPLETED | NA |
| NCT07755735 |
A Study to Evaluate the Effects of a Fiber Supplement on Gut Health |
COMPLETED | NA |
| NCT07742657 |
A Clinical Trial to Evaluate the Effects of Super Liver Liquid Drops on Gut Health, Digestive Comfort, and Daily Energy Levels |
ACTIVE_NOT_RECRUITING | NA |
| NCT07591584 |
A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating |
RECRUITING | NA |
| NCT07527286 |
The Effects of a Postbiotic Supplement on Biomarkers of Gut Health |
COMPLETED | |
| NCT07522255 |
Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders |
NOT_YET_RECRUITING | PHASE3 |
| NCT07370740 |
A Clinical Trial to Investigate the Safety and Efficacy of Bloat on Postprandial Bloating and Its Effects Over Time in Healthy Women |
NOT_YET_RECRUITING | NA |
| NCT07337343 |
Co-Development and Validation of Colonic Symptom Pictograms for Young People |
NOT_YET_RECRUITING | |
| NCT07215351 |
Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women |
COMPLETED | NA |
